Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvimopan for postoperative ileus
NCT00205842Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative ileus (POI) comparing Alvimopan with Placebo (2 arms). Primary endpoint: Time to recovery of GI function. Started Jun 2004; status: completed.
02
Drugs
alvimopan
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT00205842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205842.